Stakeholder Briefing – 26th August
Event Overview:
Date: Tuesday 26th August
Time: 8.15am for 8.30am start
Venue: Davy House, 49 Dawson Street, Dublin 2
At a time when trade policies can – and are – shifting overnight, staying informed is your very best strategy. The threat of 30% tariffs being imposed by the US on the EU was replaced with a 15% tariff celling over the weekend. While this is a relief, unfortunately the specifics – especially for sectors like pharma – are still unfolding. Much discussions are still expected to happen around the agreed framework. This continues to be a rapidly evolving and complex area which will directly affect Ireland’s pharma industry.
Against this backdrop, the PMI are delighted to collaborate with Davys for a crucial Stakeholder Briefing which will take place on August 26th in their offices on Dawson Street. During the talk, we’ll discuss the effect the US trade policies and tariffs are having on the global market and the potential impact on the Irish pharma market. Caitriona Duggan, Country Director at Amgen and current Vice President of IPHA and Paul Nicholson, Head of Investment Strategy at Davy, and will provide their respective perspectives – offering both an internal insight and a broader macroeconomic outlook.
The event will conclude with a discussion focused on practical planning considerations for senior leaders and executives in the industry. Key topics will include managing equity-based compensation, navigating cross-border complexities, and aligning long-term pension strategies with retirement planning objectives.
Why Attend?
- Gain Insights from Experts:
Caitriona Duggan, Country Director with Amgen and Vice President of IPHA, alongside Paul Nicholson, Head of Investment Strategy at Davys, will delve into the pressing issues affecting the global market and the Irish pharma sector. - Understand the Implications:
Learn about the government’s role in supporting innovation amidst these changes and how geopolitical risks are shaping financial markets. - Prepare for the Future:
With ongoing uncertainties, this event is your opportunity to gather critical insights and understanding of this complex area.
——–
Speakers:
Caitriona Duggan, Country Director – Amgen & Vice President – IPHA
Caitriona heads up the Amgen commercial business in Ireland. Before joining Amgen, she worked for Pfizer Ireland Ltd and Pharmacia & Upjohn Ltd. Caitriona’s pharmaceutical career spans both clinical and commercial, covering roles in clinical trials, sales, marketing & market access. Caitriona is also an active member of IPHA holding positions on the IPHA Board, IPHA Strategy Board and is the Chair of the Market Access Advisory Forum. Caitriona is also the current Vice President of IPHA.
She is passionate about shaping a positive healthcare environment where health & wellbeing is the foundation of a strong economy. She believes the pharmaceutical industry and life sciences sector can play a greater role in the delivery of optimal healthcare through a value-based approach. Having completed a master’s in medical informatics in her early career she very much believes that better data Infrastructure is the key to embedding and delivering value-based healthcare.
Caitriona began her career as a Haematology Nurse Specialist working in the National Bone Marrow Unit and subsequently established the Haematology clinical trials department in St. James Hospital.
Paul Nicholson CFA – Head of Investment Strategy – Davys
Paul joined Davy in Ireland as Head of Investment Strategy in 2023. Paul has over 20 years of experience in asset management, leading investment teams globally, across a range of Multi-Asset, Fixed Income, Equity, Loans and Private strategies. Previously, Paul led the fixed income team at Queensland Investment Corporation, working in both London and Brisbane. Prior to this, Paul was the Head of Absolute Return Bond Strategy at Vontobel Asset Management in Zurich, Switzerland.
Paul started his career in London, managing fixed income absolute return bond funds at HSBC Investment Management, and later with Nomura Asset Management as a financial analyst & fixed income portfolio manager. In 2006, Paul moved to Hong Kong, where he managed multi-asset class portfolios for SAIL Advisors Ltd, and later became a founding member of Synergy Fund Management Group in Hong Kong.
——-
Proudly supported by:
With over 90 years in business and more than €30 billion in assets under management, Davy provides bespoke wealth management services to high-net-worth individuals, business owners, and institutions. Within its Private Clients division, Davy has a dedicated team of advisors focused on supporting leaders and executives in the pharmaceutical industry. This team offers strategic advice to help optimise retirement outcomes, plan for early retirement, and navigate the evolving pension landscape.
Pharmaceutical executives often face unique financial challenges—such as managing equity-based compensation, addressing cross-border tax complexities, and aligning long-term pension strategies. Davy’s holistic, goal-based investment approach empowers these individuals to make informed decisions, manage investment risk, and align their financial strategies with both personal and professional ambitions.
Please note that by registering for this event you agree to share your name and company details with the organisers and the event sponsor.
